Potential response to curcumin in infantile hemangioendothelioma of the liver

A case of life‐threatening infantile hemangioendothelioma of the liver in a 6‐month‐old infant treated successfully with the dietary supplement curcumin is reported, with 6‐year follow‐up. Implications for pathogenesis based on sites of action of curcumin are considered. Pediatr Blood Cancer. 2010;5...

Full description

Saved in:

Bibliographic Details
Published in:	Pediatric blood & cancer Vol. 55; no. 2; pp. 377 - 379
Main Authors:	Hassell, Lewis A., Roanh, Le Dinh
Format:	Journal Article
Language:	English
Published:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-08-2010
Subjects:	angiogenesis factors Anti-Inflammatory Agents, Non-Steroidal Antineoplastic Agents curcumin Curcumin - therapeutic use Diagnostic Imaging Dietary Supplements Hemangioendothelioma - drug therapy Hemangioendothelioma - pathology Humans Infant infantile hemangioendothelioma of liver Liver Neoplasms - drug therapy Liver Neoplasms - pathology Remission Induction Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	A case of life‐threatening infantile hemangioendothelioma of the liver in a 6‐month‐old infant treated successfully with the dietary supplement curcumin is reported, with 6‐year follow‐up. Implications for pathogenesis based on sites of action of curcumin are considered. Pediatr Blood Cancer. 2010;55:377–379. © 2010 Wiley–Liss, Inc.
Bibliography:	ArticleID:PBC22538 istex:1EC2469A25783C3EA15974E9B1D0634B80192D85 ark:/67375/WNG-2RVHXCTV-Z Conflict of interest: Nothing to declare. ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
ISSN:	1545-5009 1545-5017
DOI:	10.1002/pbc.22538